nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-137404AD·Framework v5.0·Pipeline v0.4·Evaluated 05 Jun 2026·OECD: 3.1 Basic medicine·Subfield: Molecular Biology·Basis: Full text·Type: Laboratory experiment

Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase.

Kolas et al.Kolas, Chapman, Nakada et al.·2007·Science (New York, N.Y.)·10.1126/science.1150034 ↗

In brief

A rigorous mechanistic study that places RNF8 at the heart of ubiquitin-dependent DNA-damage signaling, constrained mainly by its distance from clinical translation.

ReliabilityCaveats4 of 4 checks completeCorrection published 10 Apr 2025Read the entry ↓
Abstract

Cells respond to DNA double-strand breaks by recruiting factors such as the DNA-damage mediator protein MDC1, the p53-binding protein 1 (53BP1), and the breast cancer susceptibility protein BRCA1 to sites of damaged DNA. Here, we reveal that the ubiquitin ligase RNF8 mediates ubiquitin conjugation and 53BP1 and BRCA1 focal accumulation at sites of DNA lesions. Moreover, we establish that MDC1 recruits RNF8 through phosphodependent interactions between the RNF8 forkhead-associated domain and motifs in MDC1 that are phosphorylated by the DNA-damage activated protein kinase ataxia telangiectasia mutated (ATM). We also show that depletion of the E2 enzyme UBC13 impairs 53BP1 recruitment to sites of damage, which suggests that it cooperates with RNF8. Finally, we reveal that RNF8 promotes the G2/M DNA damage checkpoint and resistance to ionizing radiation. These results demonstrate how the DNA-damage response is orchestrated by ATM-dependent phosphorylation of MDC1 and RNF8-mediated ubiquitination.

Strengths · Limitations

Strengths

#methodological rigour

Convergent orthogonal evidence for one mechanism

Depletion, siRNA-resistant rescue, domain-specific mutants, phosphopeptide binding, live-cell imaging, and pharmacological ATM inhibition all converge on the same MDC1-to-RNF8-to-ubiquitin-to-effector pathway. This multi-pronged design makes the central causal model robust.

↳ Results, Figs. 2-3

#methodological rigour

Rigorous specificity controls

siRNA-resistant murine RNF8 rescue distinguishes on-target from off-target RNAi effects, and FHA (R42A) versus RING (C403S) mutants cleanly separate the recruitment and catalytic functions of RNF8. These controls are exemplary for the era.

↳ Figs. 2D-F, 3A-C, S7

#contribution

Fills a defined mechanistic gap

By identifying RNF8 as the upstream ligase organizing ubiquitin signaling at double-strand breaks, the paper supplies the enzymatic step that concurrent RAP80 work lacked and links it to clinically relevant BRCA1 and 53BP1 recruitment. The advance is positioned at a critical node of an active field.

↳ Abstract; Introduction; Fig. 4E

Limitations

#methodological rigour

Minimal formal statistical reporting

Conclusions rest largely on representative images and percentage-of-cells-with-foci data, with sample sizes and statistical tests not consistently reported in the main text. This was common for 2007 cell biology but limits quantitative assessment by current standards.

↳ Results, Figs. 1-4

#contribution

Direct ubiquitinated substrate not identified

The paper shows that ubiquitin foci depend on RNF8 but does not identify the direct substrate(s), leaving a mechanistic gap between RNF8 catalytic activity and 53BP1/BRCA1 recruitment. This limitation is acknowledged only implicitly.

↳ Results; Discussion

#application pathway

Confined to transformed cell lines

Findings are established in U2OS and HeLa cells with mouse-complementation and DT40 corroboration but without primary-cell or in vivo validation. This keeps the work at a preclinical, mechanistic stage and bounds its near-term translational reach.

↳ Results; ref 26

Does this match your read? Add your assessment ↓

Nabu Commentary

The assessment is anchored by a tightly controlled experimental design in which depletion, siRNA-resistant rescue, and domain-specific FHA and RING mutants converge with phosphopeptide binding and live-cell imaging on a single mechanistic model (Figs. 2-3). The contribution scores highly because the work supplies the upstream ligase linking ATM-phosphorylated MDC1 to ubiquitin-dependent 53BP1 and BRCA1 recruitment, a step left open by concurrent RAP80 studies. Counterweighing this are sparse formal statistics and sample sizes in the main text and the unidentified direct ubiquitinated substrate, which hold the craft and contribution scores below the airtight ceiling. On impact, the functional endpoints in Fig. 4C-D (clonogenic survival and the G2/M checkpoint) supply genuine enabling biology, but the confinement to transformed cell lines without in vivo validation is the dominant constraint on near-term translation.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
4.4±0.1

Contribution
4.5

The paper fills a specific mechanistic gap by identifying RNF8 as the E3 ligase that links ATM-phosphorylated MDC1 to ubiquitin-dependent recruitment of 53BP1 and BRCA1 at double-strand breaks, providing the upstream enzymatic step that concurrent RAP80 work lacked. Claims are proportionate to convergent loss-of-function, rescue, peptide-binding, and functional evidence.

Abstract; Results and Fig. 4E model

we identify RNF8 as the prime ubiquitin ligase for poly-ubiquitination at DSB sites

Methodological Rigour
4.3

The design layers orthogonal approaches—siRNA/esiRNA depletion, siRNA-resistant murine RNF8 rescue, FHA (R42A) and RING (C403S) domain mutants, phosphopeptide pulldowns, live-cell imaging, and pharmacological ATM inhibition—into a coherent specificity-controlled dissection. The principal limitations are minimal formal statistical reporting and sample sizes in the main text and the unidentified direct ubiquitinated substrate.

Results, Figs. 2E-F, 3A-D, 4C-D

Introduction of RNAi-resistant murine RNF8 into cells transfected with RNF8 siRNA restored 53BP1 focus formation

Reporting
4.3

The argument flows logically from MDC1 TQXF phosphorylation through RNF8 recruitment and ubiquitin-chain formation to downstream effector recruitment and functional consequences, with the Fig. 4E model summarizing the pathway and hedged language where direct binding could not be shown. The connection between the independent RNAi screen and the MDC1 TQXF narrative could be more explicitly bridged.

Results, throughout; Fig. 4E

we were unable to detect such interactions (Fig. 3B), suggesting that MDC1-dependent 53BP1 IRIF formation is likely mediated by an additional factor

Positioning
4.2

The study situates itself substantively against concurrent RAP80 work (refs 13-16), the MDC1/gammaH2AX literature (refs 7-12), and explicitly addresses the complicating observation that 53BP1 foci form in ATM-deficient cells by adding pharmacological ATM-inhibition data. It lacks a formal limitations section and leaves the unidentified direct substrate only implicitly flagged, both genre-appropriate for a 2007 letter.

Introduction and Results; Fig. S4

although 53BP1 IRIF formation can occur in ATM-deficient AT cells (18, 19), we found that pharmacological inhibition of ATM impaired 53BP1 focus formation

Reliability

Caveats4 of 4 checks


Internal CoherenceClean

The mechanistic narrative is internally consistent across abstract, main text, and figures, with convergent orthogonal assays supporting the same model and negative results reported transparently.

Research ConductClean

No ethics, conflict-of-interest, or data-availability statements are present, but all are era-appropriate omissions for a 2007 basic cell-biology study using standard cell lines and commercial reagents, and none are material to interpretation.

Flags: 0 declared / 5 total

Reference IntegrityClean

All 27 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordNoted

An expression of concern was published on 2024-12-05. See notice.

Correction published 10 Apr 2025 · listed in Crossref

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Generic health relevance
Type of advanceEmpirical
Route to useNot stated
AdvanceAdvances
CitationsFWCI 27.3
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The mechanism was pinned down through siRNA depletion, mutational rescue and microscopy in cultured human cells under controlled laboratory conditions.

The conclusion describes only the molecular mechanism by which RNF8 operates in the DNA-damage response, with no stated real-world use of these findings.

Pathway

Oncology researchers could build on RNF8-dependent ubiquitin signalling to develop DDR-targeted or radiosensitising cancer therapies.

Barrier

Findings rest on cultured-cell experiments only, with no animal or human evidence linking RNF8 function to tumour behaviour or treatment response.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. RPA2 winged-helix domain facilitates UNG-mediated removal of uracil from ssDNA; implications for repair of mutagenic uracil at the replication fork

    Kavli, Iveland, Buchinger, et al. · 2021 · Biological sciences

    Primary claim

    we demonstrate that uracil-DNA glycosylase (UNG), but not SMUG1 efficiently excises uracil from replication protein A (RPA)-coated ssDNA

    Supported
    Evidence Score
    3.8±0.1
    Reliability
    Caveats
  2. Loss of IGF-1R impairs DNA-PKcs recruitment to chromatin leading to defective end-joining

    Ellis, Mills, Niedzwiedz, et al. · 2026 · Clinical medicine

    Primary claim

    Loss of IGF-1R impaired DNA-dependent protein kinase catalytic subunit (DNA-PKcs) localisation to chromatin, resulting in defective non-homologous end-joining (NHEJ) and a compensatory reliance on alternative repair pathways, including microhomology-mediated end-joining (MMEJ).

    Supported
    Evidence Score
    3.5±0.2
    Reliability
    Caveats
  3. Platelet-derived factors dysregulate placental sphingosine-1-phosphate receptor 2 in human trophoblasts

    Freya Lyssy, Jacqueline Guettler, Beatrice A Brugger, et al. · 2023 · Basic medicine

    Primary claim

    S1PR2 was found to be significantly down-regulated in BeWo cells when co-incubated with platelet-derived factors (P = 0.0055).

    Tentative
    Evidence Score
    3.1±0.2
    Reliability
    Caveats

How the rubric works →